X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/chiesi-group-signed-a-license-agreement-with-haisco-pharmaceutical-to-develop-manufacture-and-commercialise-a-novel-reversible-dipeptidyl-peptidase-1-inhibitor-for-bronchiectasis-301992400.html